XML 79 R103.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Information (Details 3) (USD $)
12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2010
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities $ 156,008,000 $ 153,267,000 $ 128,566,000
Investing Activities:      
Loans made (802,896,000) (649,249,000) (545,579,000)
Loans repaid 520,193,000 404,392,000 335,832,000
Recovery of pawn loan principal through sale of forfeited collateral 240,381,000 205,662,000 174,224,000
Additions to property and equipment (45,796,000) (34,122,000) (25,741,000)
Proceeds on disposal of assets 0 0 1,347,000
Acquisitions, net of cash acquired (128,647,000) (67,920,000) (21,837,000)
Payments for Advance to Affiliate 0    
Investments in unconsolidated affiliates 0 0 (59,188,000)
Net cash used in investing activities (216,765,000) (141,237,000) (140,942,000)
Financing Activities:      
Proceeds from exercise of stock options 649,000 397,000 1,602,000
Excess tax benefit from stock compensation 1,602,000 3,230,000 1,861,000
Debt issuance cost (3,225,000) (2,397,000) 3,000
Taxes paid related to net share settlement of equity awards (1,184,000) (7,484,000) 0
Change in restricted cash (5,482,000) 0 0
Proceeds on revolving line of credit 792,927,000 164,500,000 63,050,000
Payments on revolving line of credit (695,077,000) (147,000,000) (63,050,000)
Proceeds from bank borrowings 2,461,000 0 0
Payments on bank borrowings and capital lease obligations (8,496,000) (25,004,000) (10,000,000)
Net cash provided by (used in) financing activities 84,175,000 (13,758,000) (6,534,000)
Effect of exchange rate changes on cash and cash equivalents 1,090,000 (157,000) 0
Change in cash and equivalents 24,508,000 (1,885,000) (18,910,000)
Cash and cash equivalents at beginning of period 23,969,000 25,854,000 44,764,000
Cash and cash equivalents at end of period 48,477,000 23,969,000 25,854,000
Parent [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities (112,864,000) 13,287,000 64,309,000
Investing Activities:      
Loans made 0 0 0
Loans repaid 0 0 0
Recovery of pawn loan principal through sale of forfeited collateral 0 0 0
Additions to property and equipment 0 0 0
Proceeds on disposal of assets     0
Acquisitions, net of cash acquired 0 0 0
Payments for Advance to Affiliate 0    
Investments in unconsolidated affiliates     (57,772,000)
Net cash used in investing activities 0 0 (57,772,000)
Financing Activities:      
Proceeds from exercise of stock options 649,000 397,000 1,602,000
Excess tax benefit from stock compensation 1,602,000 3,230,000 1,861,000
Debt issuance cost 0 (1,930,000) 0
Taxes paid related to net share settlement of equity awards (1,184,000) (7,484,000) 0
Change in restricted cash 0    
Proceeds on revolving line of credit 753,200,000 0 63,050,000
Payments on revolving line of credit (640,700,000) 0 (63,050,000)
Proceeds from bank borrowings 0 2,500,000 0
Payments on bank borrowings and capital lease obligations 0 (10,000,000) (10,000,000)
Net cash provided by (used in) financing activities 113,567,000 (13,287,000) (6,537,000)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Change in cash and equivalents 703,000 0 0
Cash and cash equivalents at beginning of period 0 0 0
Cash and cash equivalents at end of period 703,000 0 0
Subsidiary Guarantors [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 141,638,000 116,011,000 47,161,000
Investing Activities:      
Loans made (638,121,000) (554,138,000) (504,305,000)
Loans repaid 408,404,000 339,574,000 313,255,000
Recovery of pawn loan principal through sale of forfeited collateral 213,115,000 183,441,000 162,407,000
Additions to property and equipment (31,064,000) (24,651,000) (16,503,000)
Proceeds on disposal of assets     1,347,000
Acquisitions, net of cash acquired (66,317,000) (62,768,000) (21,837,000)
Payments for Advance to Affiliate (20,648,000)    
Investments in unconsolidated affiliates     (1,416,000)
Net cash used in investing activities (134,631,000) (118,542,000) (67,052,000)
Financing Activities:      
Proceeds from exercise of stock options 0 0 0
Excess tax benefit from stock compensation 0 0 0
Debt issuance cost 0 (467,000) 3,000
Taxes paid related to net share settlement of equity awards 0 0 0
Change in restricted cash 0    
Proceeds on revolving line of credit 0 164,500,000 0
Payments on revolving line of credit 0 (147,000,000) 0
Proceeds from bank borrowings 0 (2,500,000) 0
Payments on bank borrowings and capital lease obligations (181,000) (15,004,000) 0
Net cash provided by (used in) financing activities (181,000) (471,000) 3,000
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Change in cash and equivalents 6,826,000 (3,002,000) (19,888,000)
Cash and cash equivalents at beginning of period 20,860,000 23,862,000 43,750,000
Cash and cash equivalents at end of period 27,686,000 20,860,000 23,862,000
Other Subsidiaries [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 127,234,000 23,969,000 17,096,000
Investing Activities:      
Loans made (164,775,000) (95,111,000) (41,274,000)
Loans repaid 111,789,000 64,818,000 22,577,000
Recovery of pawn loan principal through sale of forfeited collateral 27,266,000 22,221,000 11,817,000
Additions to property and equipment (14,732,000) (9,471,000) (9,238,000)
Proceeds on disposal of assets     0
Acquisitions, net of cash acquired (62,330,000) (5,152,000) 0
Payments for Advance to Affiliate 0    
Investments in unconsolidated affiliates     0
Net cash used in investing activities (102,782,000) (22,695,000) (16,118,000)
Financing Activities:      
Proceeds from exercise of stock options 0 0 0
Excess tax benefit from stock compensation 0 0 0
Debt issuance cost (3,225,000) 0 0
Taxes paid related to net share settlement of equity awards 0 0 0
Change in restricted cash (5,482,000)    
Proceeds on revolving line of credit 60,375,000 0 0
Payments on revolving line of credit (54,377,000) 0 0
Proceeds from bank borrowings 2,461,000 0 0
Payments on bank borrowings and capital lease obligations (8,315,000) 0 0
Net cash provided by (used in) financing activities (8,563,000) 0 0
Effect of exchange rate changes on cash and cash equivalents 1,090,000 (157,000) 0
Change in cash and equivalents 16,979,000 1,117,000 978,000
Cash and cash equivalents at beginning of period 3,109,000 1,992,000 1,014,000
Cash and cash equivalents at end of period 20,088,000 3,109,000 1,992,000
Eliminations [Member]
     
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 0    
Investing Activities:      
Loans made 0    
Loans repaid 0    
Recovery of pawn loan principal through sale of forfeited collateral 0    
Additions to property and equipment 0    
Acquisitions, net of cash acquired 0    
Payments for Advance to Affiliate 20,648,000    
Net cash used in investing activities 20,648,000    
Financing Activities:      
Proceeds from exercise of stock options 0    
Excess tax benefit from stock compensation 0    
Debt issuance cost 0    
Taxes paid related to net share settlement of equity awards 0    
Change in restricted cash 0    
Proceeds on revolving line of credit (20,648,000)    
Payments on revolving line of credit 0    
Proceeds from bank borrowings 0    
Payments on bank borrowings and capital lease obligations 0    
Net cash provided by (used in) financing activities (20,648,000)    
Effect of exchange rate changes on cash and cash equivalents 0    
Change in cash and equivalents 0    
Cash and cash equivalents at beginning of period 0    
Cash and cash equivalents at end of period $ 0